Costas Inc

PINK:CSSI USA Medical Instruments & Supplies
Market Cap
$665.99K
Market Cap Rank
#38740 Global
#12576 in USA
Share Price
$0.03
Change (1 day)
-59.26%
52-Week Range
$0.03 - $0.08
All Time High
$0.74
About

Costas, Inc., a digital media company, owns and develops Web-based consumer Internet assets and communities in the United States and India. It operates ejobresource.com, an online job portal that offers recruitment and placement services. The company also provides under graduate and graduate degree courses; and systems integration and software services. It serves the media and entertainment, agen… Read more

Costas Inc (CSSI) - Net Assets

Latest net assets as of September 2024: $-1.88 Million USD

Based on the latest financial reports, Costas Inc (CSSI) has net assets worth $-1.88 Million USD as of September 2024.

Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($171.83K) and total liabilities ($2.05 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.

Key Net Assets Metrics

Metric Value
Current Net Assets $-1.88 Million
% of Total Assets -1094.9%
Annual Growth Rate N/A
5-Year Change -218.39%
10-Year Change -1724.24%
Growth Volatility 109.17

Costas Inc - Net Assets Trend (2002–2023)

This chart illustrates how Costas Inc's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.

Annual Net Assets for Costas Inc (2002–2023)

The table below shows the annual net assets of Costas Inc from 2002 to 2023.

Year Net Assets Change
2023-12-31 $-1.60 Million -5.81%
2022-12-31 $-1.51 Million -1155.10%
2018-12-31 $-120.36K -109.24%
2017-12-31 $1.30 Million -3.51%
2016-12-31 $1.35 Million +300.61%
2015-12-31 $337.02K +39.46%
2014-12-31 $241.66K +34.42%
2013-12-31 $179.78K -0.57%
2011-12-31 $180.80K +83.72%
2010-12-31 $98.41K +67.09%
2002-12-31 $58.89K --

Equity Component Analysis

This analysis shows how different components contribute to Costas Inc's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

  • Retained earnings have decreased by 1692751000.0% over the analyzed period, potentially due to dividend distributions or operating losses.

Current Equity Component Breakdown (December 2023)

Component Amount Percentage
Common Stock $445.73K %
Other Components $14.90 Million %
Total Equity $-1.60 Million 100.00%

Costas Inc Competitors by Market Cap

The table below lists competitors of Costas Inc ranked by their market capitalization.

Equity Growth Attribution

This analysis shows how different factors contributed to changes in Costas Inc's equity between the two most recent reporting periods.

Equity Growth Insights

  • From 2022 to 2023, total equity changed from -1,510,617 to -1,598,378, a change of -87,761.
  • Net loss of 412,000 reduced equity.
  • Other comprehensive income decreased equity by 30,000.
  • Other factors increased equity by 354,239.

Equity Change Factors (2022 to 2023)

Factor Impact Contribution
Net Income $-412.00K -25.78%
Other Comprehensive Income $-30.00K -1.88%
Other Changes $354.24K +22.16%
Total Change $- %

Book Value vs Market Value Analysis

This analysis compares Costas Inc's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

Historical Price-to-Book Ratios

Date Book Value per Share Market Price P/B Ratio
2013-12-31 $0.04 $0.03 x
2014-12-31 $0.06 $0.03 x
2015-12-31 $0.02 $0.03 x
2016-12-31 $0.06 $0.03 x
2017-12-31 $0.06 $0.03 x
2018-12-31 $0.00 $0.03 x
2019-12-31 $-0.04 $0.03 x
2020-12-31 $-0.03 $0.03 x
2021-12-31 $0.00 $0.03 x
2022-12-31 $0.00 $0.03 x
2023-12-31 $0.00 $0.03 x

Capital Efficiency Dashboard

This dashboard shows how efficiently Costas Inc utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

  • Current Return on Equity (ROE): 0.00%
  • The company may be facing challenges in efficiently utilizing shareholder equity.
  • DuPont Analysis Breakdown:
  • • Net Profit Margin: -121.37%
  • • Asset Turnover: 2.19x
  • • Equity Multiplier: 0.00x
  • Recent ROE (0.00%) is above the historical average (-17.44%), indicating improving capital efficiency.

Historical Capital Efficiency Metrics

Year Return on Equity Net Profit Margin Asset Turnover Equity Multiplier Economic Value Added
2002 -23.89% -67.96% 0.35x 1.02x $-19.96K
2009 -40.96% 0.00% 0.00x 1.00x $-5.90K
2010 11.66% 24.72% 0.17x 2.81x $1.63K
2011 31.74% 38.37% 0.39x 2.15x $39.31K
2013 -2.23% -29.89% 0.04x 2.09x $-21.98K
2014 -214.35% 0.00% 0.00x 1.35x $-542.17K
2015 -15.14% -95.08% 0.10x 1.56x $-84.73K
2016 -2.65% 0.00% 0.00x 1.13x $-170.76K
2017 -5.85% 0.00% 0.00x 1.17x $-206.43K
2018 0.00% 0.00% 0.00x 0.00x $-2.19 Million
2019 0.00% 0.00% 0.00x 0.00x $39.04K
2020 0.00% 0.00% 0.00x 0.00x $50.01K
2021 0.00% 0.00% 0.00x 0.00x $-10.24 Million
2022 0.00% -953.10% 0.92x 0.00x $-1.50 Million
2023 0.00% -121.37% 2.19x 0.00x $-252.16K

Industry Comparison

This section compares Costas Inc's net assets metrics with peer companies in the Medical Instruments & Supplies industry.

Industry Context

  • Industry: Medical Instruments & Supplies
  • Average net assets among peers: $2,683,526,542
  • Average return on equity (ROE) among peers: -32.48%

Peer Company Comparison

Company Net Assets Return on Equity Debt-to-Equity Market Cap
Costas Inc (CSSI) $-1.88 Million -23.89% N/A $267.95K
ANGELALIGN TECHNOLOGY INC (AGLFF) $480.24 Million 2.52% 0.41x $405.57 Million
Akoya Biosciences Inc (AKYA) $-30.16 Million 0.00% 0.00x $16.24 Million
Alcon AG (ALC) $19.68 Billion 1.70% 0.48x $37.82 Billion
Align Technology Inc (ALGN) $3.85 Billion 10.94% 0.61x $11.75 Billion
AngioDynamics Inc (ANGO) $355.71 Million 3.06% 0.15x $354.40 Million
Ansell Limited (ANSLF) $386.33 Million -0.45% 0.87x $2.58 Billion
AptarGroup Inc (ATR) $2.07 Billion 11.57% 1.03x $8.27 Billion
AtriCure Inc (ATRC) $72.60 Million -15.79% 0.54x $1.42 Billion
Avinger Inc (AVGR) $-35.69 Million 0.00% 0.00x $1.26 Million
Anteris Technologies Global Corp. Common Stock (AVR) $9.03 Million -338.35% 0.77x $156.14 Million